Drupal.behaviors.print = function(context) {window.print();window.close();}>
Orchid Cellmark's Q1 Revenues Rise 18 Percent
May 16, 2011
Orchid Cellmark's Q1 Revenues Rise 18 Percent
While US revenues were flat, UK business increased 28 percent from a year ago.
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
UK Business Drives up Orchid Cellmark's Q3 Revenues 18 Percent
November 4, 2010 / GenomeWeb Daily News
Vermillion's OVA1 Sales Increase 8 Percent in Q1
May 16, 2013 / GenomeWeb Daily News
Cancer Genetics Reports 45 Percent Increase in Q1 Revenues, Maps out Growth Strategy
May 16, 2013 / GenomeWeb Daily News
RXi Q1 Loss Rises on Opko Deal Charge
May 16, 2013 / Gene Silencing News
Trovagene's Q1 Revenues Rise
May 15, 2013 / GenomeWeb Daily News